Changes in biomarkers of exposure and subjective effects when smokers switch to dual use of cigarettes and either snus or a dissolvable tobacco product: A summary of three clinical studies

Beitrage zur Tabakforschung International/ Contributions to Tobacco Research

Volumn 26, Issue 6, 2015, Pages 242-260

  Round, Elaine K ^a   Campbell, Leanne R ^a   Stiles, Mitchell F ^a   Dixon, Michael ^b   Borgerding, Michael F ^a  

^a R J REYNOLDS TOBACCO COMPANY   (United States)

^b Dixon Consultancy   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85114897771     PISSN: 0173783X     EISSN: 16129237     Source Type: Journal    
DOI: 10.1515/cttr-2015-0013     Document Type: Article

References (56)

1. Department of Health and Human Services, Food and Drug Administration: Deeming Tobacco Products to be Subject to the Federal Food, Drug, and Cosmetic Act, As Amended by the Family Smoking Prevention and Tobacco Control Act; Regulations on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products; Proposed Rules; Fed. Regist. 79 (2014) 23142-23207, available at: http://www.gpo.gov/fdsys/pkg/FR-2014-04-25/pdf/2014-09491.pdf (accessed April 2015).
2. Stratton, K., P. Shetty, R. Wallace, and S. Bondurant (Editors): Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction; National Academies Press, Washington, DC, USA, 2001.
3. Zeller, M. and D. Hatsukami: The Strategic Dialogue on Tobacco Harm Reduction: A Vision and Blueprint for Action in the US; Tob. Control 18 (2009) 324-332.
4. Foulds, J., L. Ramstrom, M. Burke, and K. Fagerström: Effect of Smokeless Tobacco (Snus) on Smoking and Public Health in Sweden; Tob. Control 12 (2003) 349-359.
5. Roth, D.H., A.B. Roth, and X. Liu: Health Risks of Smoking Compared to Swedish Snus; Inhal. Toxicol. 17 (2005) 741-748.
6. Schildt, E.B., M. Eriksson, L. Hardell, and A. Magnuson: Oral Snuff, Smoking Habits and Alcohol Consumption in Relation to Oral Cancer in a Swedish Case-Control Study; Int. J. Cancer 77 (1998) 341-346.
7. Tobacco Products Scientific Advisory Committee: Summary: TPSAC Report on Dissolvable Tobacco Products; 2012, available at: http://www.fda.gov/ downloads/advisorycommittee/committeemeeting materials/tobaccoproductsscientificadvisorycommittee/ ucm290182.pdf (accessed April 2015).
8. Sarkar, M., J. Liu, T. Koval, J. Wang, S. Feng, R. Serafin, Y. Jin, Y. Xie, K. Newland, and H.J. Roethig: Evaluation of Biomarkers of Exposure in Adult Smokers Using Marlboro Snus; Nicotine Tob. Res. 12 (2010) 105-116.
9. Krautter, G.R. and M.F. Borgerding: Comparison of Consumption Patterns, Biomarkers of Exposure and Subjective Effects in Cigarette Smokers Switched to Dissolvable Tobacco (Camel Orbs), Dual Use, or Tobacco Abstinence; Nicotine Tob. Res. 16 (2014) 1336-1347, doi:10.1093/ntr/ntu082.
10. Krautter, G.R., P.X. Chen, and M.F. Borgerding: Consumption Patterns and Biomarkers of Exposure in Cigarette Smokers Switched to Snus, Various Dissolvable Tobacco Products, Dual Use, or Tobacco Abstinence; Regul. Toxicol. Pharmacol. 71 (2015) 186-197.
11. Health Canada: Official Method T-310-Determination of Whole Tobacco pH; Health Canada, Ottawa, Canada, 1999.
12. AOAC: AOAC Method 966.02, Moisture in tobacco; in: Official Methods of Analysis of AOAC International, AOAC International, Gaithersburg, MD, USA, 2000, pp. 2387-2417.
13. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention: Revised Protocol for Analysis of Nicotine, Total Moisture, and pH in Smokeless Tobacco Products; Federal Register, Volume 73, Number 121, p. 35396-35402, Washington, D.C., June 23, 2008, available at: http://www.gpo.gov/ fdsys/pkg/FR-2008-06-23/pdf/E8-14112.pdf
14. Wu, W., D.L. Ashley, and C.H. Watson: Simultaneous Determination of Five Tobacco-Specific Nitrosamines in Mainstream Cigarette Smoke by Isotope Dilution Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry; Anal. Chem. 75 (2003) 4827-4832.
15. Wagner, K.A., N.H. Finkel, J.E. Fossett, and I.G. Gillman: Development of a Quantitative Method for the Analysis of Tobacco-Specific Nitrosamines in Mainstream Cigarette Smoke Using Isotope Dilution Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry; Anal. Chem. 77 (2005) 1001-1006.
16. Wu, J., P. Joza, M. Sharifi, W.S. Rickert, and J.H. Lauterbach: Quantitative Method for the Analysis of Tobacco-Specific Nitrosamines in Cigarette Tobacco and Mainstream Cigarette Smoke by Use of Isotope Dilution Liquid Chromatography Tandem Mass Spectrometry; Anal. Chem. 80 (2008) 1341-1345.
17. AOAC: AOAC Method 973.30, Polycyclic Aromatic Hydrocarbons and Benzo[a]pyrene in Food-Spectrophotometric Method; in: Official Methods of Analysis of AOAC International, AOAC International, Gaithersburg, MD, USA, 1995, pp. 1176-1178.
18. Tomkins, B.A., R.A. Jenkins, W.H. Griest, R.R. Reagan, and S.K. Holladay: Liquid Chromatographic Determination of Benzo[a]pyrene in Total Particulate Matter of Cigarette Smoke; J. Assoc. Off. Anal. Chem. 65 (1985) 935-940.
19. Gmeiner, G., G. Stehlik, and H. Tausch: Determination of Seventeen Polycyclic Aromatic Hydrocarbons in Tobacco Smoke Condensate; J. Chromatogr. A 767 (1997) 163-169.
20. Rutqvist, L.E., M. Curvall, T. Hassler, T. Ringberger, and I. Wahlberg: Swedish Snus and the GothiaTek® Standard; Harm Reduct. J. 8 (2011) 11.
21. Nelson, P.R., P. Chen, M. Dixon, and T. Steichen: A Survey of Mouth Level Exposure to Cigarette Smoke in the United States; Regul. Toxicol. Pharmacol. 61 (2011) Suppl. 3, S25-S38.
22. St Charles, F.K., M. Ashley, C.J. Shepperd, P. Clayton, and G. Errington: A Robust Method for Estimating Human Smoked Cigarette Yields From Filter Analysis Data; Beitr. Tabakforsch. Int. 23 (2009) 232-243.
23. Caraway, J.C. and P.X. Chen: Assessment of Mouth-Level Exposure to Tobacco Constituents in U.S. Snus Consumers; Nicotine Tob. Res.15 (2013) 670-677.
24. International Organization for Standardization (ISO): ISO 3308:2000-Routine analytical cigarette-smoking machine--Definitions and standard conditions; ISO, Geneva, Switzerland, 2000.
25. Health Canada: Official Method T-111-Determination of Nitrosamines in Mainstream Tobacco Smoke; Health Canada, Ottawa, Canada, 1999.
26. Health Canada: Official Method T-115-Determination of "Tar", Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke; Health Canada, Ottawa, Canada, 1999.
27. Meger, M., I. Meger-Kossien, A. Schuler-Metz, D. Janket, and G. Scherer: Simultaneous Determination of Nicotine and Eight Nicotine Metabolites in Urine of Smokers Using Liquid Chromatography-Tandem Mass Spectrometry; J. Chromatogr. B 778 (2002) 251-261.
28. th Edition; W.B. Saunders Company, St. Louis, MO, USA, 2006.
29. Kavvadias, D., G. Scherer, M. Urban, F. Cheung, G. Errington, J. Shepperd, and M. McEwan: Simultaneous Determination of Four Tobacco-specific N-nitrosamines (TSNA) in Human Urine; J. Chromatogr. B 877 (2009) 1185-1192.
30. Urban, M., D. Kavvadias, K. Riedel, G. Scherer, and A.R. Tricker: Urinary Mercapturic Acids and a Haemoglobin Adduct for the Dosimetry of Acrylamide Exposure in Smokers and Nonsmokers; Inhal. Toxicol. 18 (2006) 831-839.
31. Riedel, K., G. Scherer, J. Engl, H.-W. Hagedorn, and A.R. Tricker: Determination of Three Carcinogenic Aromatic Amines in Urine of Smokers and Nonsmokers; J. Anal. Toxicol. 30 (2006) 187-195.
32. Ramsauer, B., K. Sterz, H.-W. Hagedorn, J. Engl, G. Scherer, M. McEwan, G. Errington, J. Shepperd, and F. Cheung: A Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) Method for the Determination of Phenolic Polycyclic Aromatic Hydrocarbons (OH-PAH) in Urine of Non-Smokers and Smokers; Anal. Bioanal. Chem. 399 (2011) 877-889.
33. Paci, E., D. Pigini, A.M. Cialdella, P. Faranda, and G. Tranfo: Determination of Free and Total S-phenylmercapturic Acid by HPLC/MS/MS in the Biological Monitoring of Benzene Exposure; Biomarkers 12 (2007) 111-122.
34. Sterz, K., D. Köhler, T. Schettgen, and G. Scherer: Enrichment and Properties of Urinary pre-SPhenylmercapturic Acid (pre-SPMA); J. Chromatogr. B 878 (2010) 2502-2505.
35. Scherer, G., M. Urban, H.-W. Hagedorn, S. Feng, R.D. Kinser, M. Sarkar, Q. Liang, and H.-J. Roethig: Determination of Two Mercapturic Acids Related to Crotonaldehyde in Human Urine: Influence of Smoking; Hum. Exp. Toxicol. 26 (2007) 37-47.
36. Urban, M., G. Gilch, G. Schepers, E. van Miert, and G. Scherer: Determination of the Major Mercapturic Acids of 1,3-Butadiene in Human and Rat Urine Using Liquid Chromatography with Tandem Mass Spectrometry; J. Chromatogr. B 796 (2003) 131-140.
37. Scherer, G., M. Urban, H.-W. Hagedorn, R. Serafin, S. Feng, S. Kapur, R. Muhammad, Y. Jin, M. Sarkar, and H.-J. Roethig: Determination of Methyl-, 2-Hydroxyethyl-, and 2-Cyanoethylmercapturic Acids as Biomarkers of Exposure to Alkylating Agents in Cigarette Smoke; J. Chromatogr. B 878 (2010) 2520-2528.
38. Toraño, J.S. and H.J. van Kan: Simultaneous Determination of the Tobacco Smoke Uptake Parameters Nicotine, Cotinine and Thiocyanate in Urine, Saliva and Hair, Using Gas Chromatography-Mass Spectrometry for Characterisation of Smoking Status of Recently Exposed Subjects; Analyst 128 (2003) 838-843.
39. Hughes, J.R. and D. Hatsukami: Signs and Symptoms of Tobacco Withdrawal; Arch. Gen. Psychiatry 43 (1986) 289-294.
40. Hughes, J.R: Effect of Abstinence From Tobacco: Valid Symptoms and Time Course; Nicotine Tob. Res. 9 (2007) 315-327
41. th Edition; American Psychiatric Association, Washington, DC, USA, 2000.
42. Benowitz, N.L., P. Jacob III, L.T. Kozlowski, and L. Yu: Influence of Smoking Fewer Cigarettes on Exposure to Tar, Nicotine, and Carbon Monoxide; N. Engl. J. Med. 315 (1986) 1310-1313.
43. Fagerström, K.O. and J.R. Hughes: Nicotine Concentrations with Concurrent Use of Cigarettes and Nicotine Replacement: A Review; Nicotine Tob. Res. 4 Suppl. 2 (2002) S73-S79.
44. Hecht, S.S., S.E. Murphy, S.G. Carmella, C.L. Zimmerman, L. Losey, I. Kramarczuk, M.R. Roe, S.S. Puumala, Y.S. Li, C. Le, J. Jensen, and D.K. Hatsukami: Effects of Reduced Cigarette Smoking on the Uptake of a Tobacco-Specific Lung Carcinogen; J. Natl. Cancer Inst. 96 (2004) 107-115.
45. Hecht, S.S., S.G. Carmella, K.-A. Le, S.E. Murphy, Y.S. Li, C. Le, J. Jensen, and D.K. Hatsukami: Effects of Reduced Cigarette Smoking on Levels of 1-Hydroxypyrene in Urine; Cancer Epidemiol. Biomarkers Prev. 13 (2004) 834-842.
46. Hurt, R.D., G.A. Croghan, T.D. Wolter, I.T. Croghan, K.P. Offord, G.M. Williams, M.V. Djordjevic, J.P. Richie, and A.M. Jeffrey: Does Smoking Reduction Result in Reduction of Biomarkers Associated with Harm? A Pilot Study Using a Nicotine Inhaler; Nicotine Tob. Res. 2 (2000) 327-336.
47. Theophilus E.H., C.R.E. Coggins, P. Chen, E. Schmidt, and M.F. Borgerding: Magnitudes of Biomarker Reductions in Response to Controlled Reductions in Cigarettes Smoked Per Day: A One-Week Clinical Confinement Study; Regul. Toxicol. Pharmacol. 71 (2015) 225-234.
48. Armitage, A.K., M. Dixon, B.E. Frost, D.C. Mariner, and N.M. Sinclair: The Effect of Inhalation Volume and Breath-hold on the Retention of Nicotine and Solanesol in the Human Respiratory Tract and on Subsequent Plasma Nicotine Concentration During Cigarette Smoking; Beitr. Tabakforsch. Int. 21 (2004) 240-249.
49. Feng, S., S.E. Plunkett, K. Lam, S. Kapur, R. Muhammad, Y. Jin, M. Zimmermann, P. Mendes, R. Kinser, and H.J. Roethig: A New Method for Estimating the Retention of Selected Smoke Constituents in the Respiratory Tract of Smokers During Cigarette Smoking; Inhal. Toxicol. 19 (2007) 169-179.
50. Moldoveanu, S., W. Coleman III, and J. Wilkins: Determination of Carbonyl Compounds in Exhaled Cigarette Smoke; Beitr. Tabakforsch. Int. 22 (2007) 346-357.
51. Moldoveanu, S., W. Coleman III, and J. Wilkins: Determination of Benzene and Toluene in Exhaled Cigarette Smoke; Beitr. Tabakforsch. Int. 23 (2008) 107-114.
52. Stone, A.A., S. Shiffman, J.E. Schwartz, J.E. Broderick, and M.R. Hufford: Patient Compliance with Paper and Electronic Diaries; Control. Clin. Trials 24 (2003) 182-199.
53. Broderick, J.E., J.E. Schwartz, S. Shiffman, M.R. Hufford, and A.A. Stone: Signaling Does Not Adequately Improve Diary Compliance; Ann. Behav. Med. 26 (2003) 139-148.
54. Hecht, S.S., S.G. Carmella, M. Chen, J.F. Dor Koch, A.T. Miller, S.E. Murphy, J.A. Jensen, C.L. Zimmerman, and D.K. Hatsukami: Quantitation of Urinary Metabolites of a Tobacco-Specific Lung Carcinogen After Smoking Cessation; Cancer Res. 59 (1999) 590-596.
55. Hecht, S.S., S.G. Carmella, M. Ye, K.-A. Le, J.A. Jensen, C.L. Zimmerman, and D.K. Hatsukami: Quantitation of Metabolites of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone after Cessation of Smokeless Tobacco Use; Cancer Res. 62 (2002) 129-134.
56. Goniewicz, M.L., C.M. Havel, M.W. Peng, P. Jacob III, D. Dempsey, L. Yu, W. Zielinska-Danch, B. Koszowski, J. Czogala, A. Sobczak, and N.L. Benowitz: Elimination Kinetics of the Tobacco-Specific Biomarker and Lung Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol; Cancer Epidemiol. Biomarkers Prev. 18 (2009) 3421-3425.